AUNA (AUNA) Q3 2025: $500M Mexico Expansion Plan Anchors Recovery Amid Segment Divergence
AUNA’s third quarter exposed sharp divergence between resilient Andean operations and ongoing Mexican recovery, with a $500 million Mexico expansion plan, new leadership, and partnership with SOGIT signaling a strategic inflection for 2026. Despite flat consolidated results, Peru and Colombia delivered margin gains and stable cash flow, offsetting Mexico’s underperformance. The company’s debt-neutral growth approach and public-private partnerships like TREKA position AUNA to capture long-term value across Latin America.
Summary
- Mexico Turnaround Pivots on SOGIT Partnership: Co-investment plan aims to accelerate growth while preserving leverage discipline.
- Peru and Colombia Offset Regional Volatility: Integrated model and risk mitigation drive margin expansion and reliable cash flow.
- 2026 Targeted as Recovery Year: Management signals full rebound in Mexico and renewed operating leverage next year.
Performance Analysis
AUNA’s Q3 2025 results reflected a mixed regional story, with consolidated FX-neutral revenue up 1%, driven by 9% growth in Peru and 4% in Colombia, while Mexico declined 12%. Segment divergence was stark: Peru’s scalable, integrated platform delivered double-digit EBITDA growth and margin expansion, supported by improved pricing mix and strong insurance plan performance (OncoSalud, oncology health plans, saw 8% revenue growth and MLR—medical loss ratio—falling to 49.3%). Colombia benefited from risk-sharing models and payer diversification, with prospective global payments (PGP, capitated contracts) rising to 18% of revenue, offsetting lower surgical volumes from government payer exposure.
Mexico remained the principal drag, with legacy volume recovery and IT system migration issues impacting both revenue and margin. However, hospital operations stabilized sequentially, with surgery volumes rising for a second quarter and oncology/cardiology services jumping 48% quarter-over-quarter. AUNA’s consolidated adjusted EBITDA fell 5% FX-neutral, but net income remained positive, aided by lower interest expense and improved debt structure.
- Segment Divergence: Peru and Colombia’s combined top-line growth offset Mexico’s decline, highlighting the benefits of a diversified regional platform.
- Margin Expansion in Core Markets: Peru’s EBITDA margin rose to 22.7%, Colombia expanded 1.7 points, while Mexico’s margin held at 29% despite revenue pressure.
- Cash Flow Resilience: Operating cash flow dipped 5% YTD, but sequential improvement in Colombia collections and disciplined capex aided liquidity.
Capacity utilization dynamics underscored the operational split: Peru’s utilization increased modestly, while Mexico and Colombia saw declines due to market-specific headwinds and deliberate risk management actions. The company’s debt refinancing and successful bond/term loan issuance further enhanced financial flexibility.
Executive Commentary
"In this quarter, we're reporting weaker financial results, a flat quarter, principally dragged down by our Mexican operations. However, in Mexico, we are seeing evidence of stable and growing operational activity... We anticipate 2026 to be a year of full recovery in Mexico, and with the New Mexico team in place, we remain very bullish in the medium term."
Sousa Zamora, Executive Chairman and President
"Peru still accounted for well over half of our platform's third quarter and year-to-date revenues. And with its top line increasing 9% in the quarter, Peru continues being a strong and reliable driver of growth and cash flow... We expect EBITDA growth in 2026 as we advance the implementation of our business model, as various growth initiatives gradually gain traction."
Giselle Remy, Chief Financial Officer and Executive Vice President
Strategic Positioning
1. Mexico: Inflection Point via SOGIT Partnership
AUNA’s $500 million, five-year Mexico expansion plan is now anchored by a formal MOU with SOGIT, a local healthcare group, enabling co-investment without overextending the balance sheet. This approach is designed to accelerate market share capture in Monterrey and other cities, while maintaining leverage discipline (targeting sub-3x net debt/EBITDA). The plan includes new hospital capacity, oncology centers, and a push into higher-margin out-of-pocket and corporate segments.
2. Andean Markets: Integrated Model and Risk Management
Peru’s integrated platform continues to demonstrate scale advantages, with OncoSalud’s insurance risk managed through tight MLR control and continuous repricing. In Colombia, risk mitigation via payer diversification and PGP contracts has reduced exposure to government-intervened payers, supporting margin stability even as sector volatility persists.
3. Operational Levers: Talent, IT, and Service Mix
Mexico’s operational reset includes revamped local leadership, new commercial and medical heads, and productivity initiatives targeting the top 140 physicians. IT system harmonization, despite near-term disruption, is a multi-year effort to standardize data and cost control across geographies. Product mix is shifting toward higher-complexity, higher-margin services—oncology and cardiology now 15% of Mexico revenue and growing rapidly.
4. Debt Structure and Capital Allocation
Recent refinancing—$765 million across senior secured notes and peso term loans—reduced interest costs by 125 basis points, extended maturities, and added IFC as a new anchor lender. AUNA’s public-private partnership (PPP) model, illustrated by the TREKA project in Peru, enables debt-neutral, long-duration revenue streams from state contracts, further insulating the balance sheet from macro shocks.
Key Considerations
This quarter’s results highlight the importance of geographic and business model diversification for AUNA, as well as the challenges of scaling in new markets like Mexico. Investors should monitor execution on the following fronts:
Key Considerations:
- Mexico Turnaround Timeline: Management expects 2026 to mark a full recovery, with KPIs including occupancy, payer mix, and surgical productivity as leading indicators.
- PPP and Debt-Neutral Growth: TREKA and future PPPs offer scale without balance sheet risk, supporting long-term revenue visibility.
- Share Price Volatility: Recent underperformance is attributed to a competitor’s block sale, not fundamentals; board is evaluating options to support valuation.
- Operational Execution on IT and Talent: Successful integration and physician engagement are critical to Mexico’s margin and volume rebound.
Risks
Execution risk in Mexico remains elevated as legacy volume recovery, IT system migration, and physician alignment continue. Political and payer instability in Colombia could pressure collections and margins if risk-sharing models falter. Macroeconomic headwinds, regulatory shifts, and competition for healthcare talent—especially in Monterrey—pose additional challenges. Management’s ability to deliver on the SOGIT partnership and PPP pipeline without overextending leverage will be closely scrutinized.
Forward Outlook
For Q4 2025, AUNA expects:
- Continued recovery in Mexico volumes and sequential margin stabilization
- Stable growth in Peru and Colombia, with focus on cash flow and payer diversification
For full-year 2025, management maintained a flat outlook, but signaled 2026 as a growth year, especially for Mexico. Guidance remains cautious on near-term leverage, but the company is committed to sub-3x net debt/EBITDA and debt-neutral expansion.
- Mexico revenue growth to resume in 2026
- PPP projects like TREKA to begin contributing by 2027
Management emphasized that operational KPIs—capacity utilization, payer mix, and physician productivity—will determine the pace of Mexico’s rebound and segment margin expansion.
Takeaways
AUNA’s diversified platform absorbed Mexico’s drag, with Andean operations delivering margin and cash flow stability. The SOGIT partnership and TREKA PPP represent strategic levers for debt-neutral growth and risk-managed expansion. Investors should watch for tangible Mexico turnaround signs and continued disciplined capital allocation as the company targets a 2026 inflection.
- Segment Resilience: Peru and Colombia’s integrated models and risk management offset Mexico’s underperformance, proving the value of regional diversification.
- Strategic Inflection in Mexico: The $500 million SOGIT-backed expansion is a bet on operational reset and market share capture, but requires flawless execution and margin discipline.
- 2026 as Pivotal Year: Recovery in Mexico and ramping PPP projects will be critical to restoring growth and operating leverage; investors should track KPIs and capital discipline closely.
Conclusion
AUNA’s Q3 2025 results underscore both the challenges of cross-market healthcare expansion and the resilience of a diversified, risk-managed platform. The company’s strategic focus on Mexico turnaround, PPP-driven growth, and disciplined leverage positions it for a critical inflection in 2026. Execution in the next 12 months will determine whether AUNA can translate these strategic bets into sustainable shareholder value.
Industry Read-Through
AUNA’s experience highlights the operational and financial complexity of scaling integrated healthcare across Latin America. The successful use of PPPs and debt-neutral expansion models offers a blueprint for capital-constrained growth in emerging markets. The segment divergence seen here—stable Andean operations versus Mexican volatility—mirrors broader regional healthcare dynamics, where payer risk, talent scarcity, and technology integration remain pivotal. Investors in the sector should monitor the interplay between public-private partnerships, capital structure flexibility, and local execution as drivers of long-term value.